These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 6773172
1. Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction. Cucuianu MP, Missits I, Olinic N, Roman S. Thromb Haemost; 1980 Feb 29; 43(1):41-4. PubMed ID: 6773172 [Abstract] [Full Text] [Related]
2. [Elevated levels of plasma von Willebrand factor: a new risk factor for atherosclerosis?]. Belicová M, Kubisz P, Kicko V, Dvorský J, Funiak S, Kvĕtenský J, Ivanková J. Vnitr Lek; 1994 Oct 29; 40(10):660-2. PubMed ID: 7810085 [Abstract] [Full Text] [Related]
3. Increased level of plasma factor VIII-related antigen in peripheral arterial disease. Uza G, Opincaru N, Cristea A, Rus HG, Cucuianu M. Med Interne; 1985 Oct 29; 23(3):171-5. PubMed ID: 3931204 [Abstract] [Full Text] [Related]
4. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage? Giustolisi R, Musso R, Cacciola E, Cacciola RR, Russo M, Petralito A. Thromb Haemost; 1984 Jul 29; 51(3):408. PubMed ID: 6437008 [No Abstract] [Full Text] [Related]
5. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, Rosendaal FR. Thromb Haemost; 1999 May 29; 81(5):680-3. PubMed ID: 10365736 [Abstract] [Full Text] [Related]
6. Plasma fibronectin in peripheral arterial disease. Rus HG, Cucuianu AM, Galea F, Cristea A, Uza G, Cucuianu M. Med Interne; 1985 May 29; 23(4):271-6. PubMed ID: 3937216 [Abstract] [Full Text] [Related]
7. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY. Eur Heart J; 2004 Mar 29; 25(5):371-6. PubMed ID: 15033248 [Abstract] [Full Text] [Related]
8. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Zeitler H, Ko Y, Zimmermann C, Nickenig G, Glänzer K, Walger P, Sachinidis A, Vetter H. Eur J Med Res; 1997 Sep 29; 2(9):389-94. PubMed ID: 9300936 [Abstract] [Full Text] [Related]
9. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand Factor. Coca M, Cucuianu M, Hâncu N. Rom J Intern Med; 2005 Sep 29; 43(1-2):115-26. PubMed ID: 16739871 [Abstract] [Full Text] [Related]
10. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. Semenov AV, Kogan-Ponomarev MIa, Ruda MIa, Komarov AL, Panchenko EP, Chazova IE, Mazurov AV. Ter Arkh; 2000 Sep 29; 72(4):15-20. PubMed ID: 10833791 [Abstract] [Full Text] [Related]
11. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Freestone B, Lip GY, Chong AY, Nadar S, Lee KW, Blann AD. Thromb Haemost; 2005 Oct 29; 94(4):702-6. PubMed ID: 16270620 [Abstract] [Full Text] [Related]
12. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Blood Coagul Fibrinolysis; 2006 Jan 29; 17(1):39-45. PubMed ID: 16607078 [Abstract] [Full Text] [Related]
13. [Factor VIII complex activities in acute leukemia]. Pniejnia-Olszyński W, Lopaciuk S. Acta Haematol Pol; 1980 Jan 29; 11(4):239-47. PubMed ID: 6794320 [Abstract] [Full Text] [Related]
14. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A. Haematologia (Budap); 1994 Jan 29; 26(2):97-109. PubMed ID: 7890268 [Abstract] [Full Text] [Related]
15. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease. Lubetsky A, Schulman S, Varon D, Martinowitz U, Kenet G, Gitel S, Inbal A. Thromb Haemost; 1999 Feb 29; 81(2):229-33. PubMed ID: 10063997 [Abstract] [Full Text] [Related]
16. Plasma concentration of von Willebrand factor in acute myocardial infarction. Sakai H, Goto S, Kim JY, Aoki N, Abe S, Ichikawa N, Yoshida M, Nagaoka Y, Handa S. Thromb Haemost; 2000 Aug 29; 84(2):204-9. PubMed ID: 10959690 [Abstract] [Full Text] [Related]
17. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I. Thromb Haemost; 1998 Nov 29; 80(5):749-56. PubMed ID: 9843166 [Abstract] [Full Text] [Related]
18. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. J Hypertens; 1995 Dec 29; 13(12 Pt 2):1674-8. PubMed ID: 8903631 [Abstract] [Full Text] [Related]
19. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Gardemann A, Schwartz O, Haberbosch W, Katz N, Weiss T, Tillmanns H, Hehrlein FW, Waas W, Eberbach A. Thromb Haemost; 1997 Jun 29; 77(6):1120-6. PubMed ID: 9241743 [Abstract] [Full Text] [Related]
20. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients]. Horváth B, Hegedüs D, Szapáry L, Márton Z, Alexy T, Koltai K, Gyevnár Z, Juricskay I, Tóth K, Késmárky G. Orv Hetil; 2003 Dec 14; 144(50):2471-6. PubMed ID: 15067986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]